The ultimate goal of metabolomics is the comprehensive study of low molecular weight molecules in living organisms. Metabolites are the result of biological and environmental factors and, therefore, offer great potential for bridging genotypic and phenotypic knowledge. Untargeted metabolomics, also known as discovery metabolomics, is used when there is no intended research target. Its characteristic is to characterize as many metabolites as possible and cover more metabolic pathways. BOC Sciences' non-targeted metabolomics based on deuterium isotope labeling combined with liquid chromatography-mass spectrometry (LC-MS) enables accurate and rapid analysis of various biological samples for disease diagnosis, pathological research, new drug development, drug toxicology, etc. Offers new perspectives for exploration.
For labile hydrogen atoms in functional groups such as hydroxyl, carboxyl, or amide, the hydrogen atoms are replaced by reacting the compound with deuterium reagents such as D2O and ND3 in the liquid or gas phase. The resulting deuterated samples are analyzed using LC-MS in full scan mode, and the number of labile hydrogen atoms on the corresponding functional groups in the molecule can then be counted, yielding structural information about the metabolites detected in complex mixtures. It is also possible to first perform hydrogen-deuterium exchange on the target compound and then analyze deuterated compounds by MS2, where the rearrangement of unstable hydrogen atoms and deuterium atoms occurs with the added energy.
The data processing workflow includes noise filtering, peak detection, peak deconvolution, retention time alignment, and finally feature annotation.
Facilitates metabolite identification in untargeted metabolomics and can potentially be extended to other types of metabolites
Widely used in environmental analysis, nutritional research, gut microbe-host interactions, biomarker discovery, identification of active metabolites, etc.
Collect data without pre-existing knowledge
Adopt the most stringent QC system to ensure qualitative and quantitative results for each item
Professional, reliable and guaranteed pre-sales and after-sales, and responsible for data publication to the end
Fig.1 Exclusion of unreasonable candidates using HDS–CIL–LC–MS.[1]
If you are interested in our services, please contact us immediately, then fill in the complete inquiry form, and we will reply to you as soon as possible.
Reference
BOC Sciences' DCL™ platform provides a deuterium strategy for both high-end custom markets and basic product needs. Our main business areas cover drug development, omics analysis, scientific research testing, and other markets, and strive to promote the development of biomedicine and scientific research.